Skip to main content
. 2021 Jan 27;224(6):1039–1047. doi: 10.1093/infdis/jiab043

Figure 4.

Figure 4.

Cumulative relapse of mice treated with bedaquiline, delamanid, and linezolid (BDL) or isoniazid, rifampicin, pyrazinamide, and ethambutol (HRZE) between 8 and 24 weeks. Solid line represents BDL group; dotted line, HRZE group.